New Preventive Treatment

apothecary-chemist-crush-39522

FDA APPROVES FIRST CGRP INHIBITOR FOR PREVENTION OF MIGRAINE ATTACKS
“For years the migraine community has been advocating for new treatment options that are specifically designed to treat migraine, a debilitating and often stigmatized disease. Today we celebrate the tireless work of researchers to better understand the biology of migraine and their ability to bring a new therapeutic approach to the millions of Americans who are seeking fewer migraine days. On behalf of the community, we would also like to thank the thousands of clinical trial patients whose unwavering commitment made this progress possible.”
-Kevin Lenaburg, Executive Director, CHAMP

Leave a Reply

%d bloggers like this: